Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saara A Koskela

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Brazilian Journal of Microbiology : [Publication of the Brazilian Society for Microbiology]|September 19, 2023
From antimicrobial to anticancer: the pioneering works of Prof. Luiz Rodolpho Travassos on bioactive peptidesSaara A Koskela, Carlos R Figueiredo
Frontiers in Immunology|April 20, 2023
Epigenetic control of <i>CD1D</i> expression as a mechanism of resistance to immune checkpoint therapy in poorly immunogenic melanomasMona Meng Wang, Saara A Koskela, Arfa Mehmood, et al.
The Journal of Pathology|February 24, 2023
Novel prognostication biomarker adipophilin reveals a metabolic shift in uveal melanoma and new therapeutic opportunitiesMaisoon Matareed, Eleftheria Maranou, Saara A Koskela, et al.
Genes and Immunity|May 22, 2024
TIMP-1 is an activator of MHC-I expression in myeloid dendritic cells with implications for tumor immunogenicityMiriam Langguth, Eleftheria Maranou, Saara A Koskela, et al.
Cell Reports|December 1, 2023
PIM kinases regulate early human Th17 cell differentiationTanja Buchacher, Ankitha Shetty, Saara A Koskela, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Brazilian Journal of Microbiology : [Publication of the Brazilian Society for Microbiology]|September 19, 2023
From antimicrobial to anticancer: the pioneering works of Prof. Luiz Rodolpho Travassos on bioactive peptidesSaara A Koskela, Carlos R Figueiredo
Frontiers in Immunology|April 20, 2023
Epigenetic control of <i>CD1D</i> expression as a mechanism of resistance to immune checkpoint therapy in poorly immunogenic melanomasMona Meng Wang, Saara A Koskela, Arfa Mehmood, et al.
The Journal of Pathology|February 24, 2023
Novel prognostication biomarker adipophilin reveals a metabolic shift in uveal melanoma and new therapeutic opportunitiesMaisoon Matareed, Eleftheria Maranou, Saara A Koskela, et al.
Genes and Immunity|May 22, 2024
TIMP-1 is an activator of MHC-I expression in myeloid dendritic cells with implications for tumor immunogenicityMiriam Langguth, Eleftheria Maranou, Saara A Koskela, et al.
Cell Reports|December 1, 2023
PIM kinases regulate early human Th17 cell differentiationTanja Buchacher, Ankitha Shetty, Saara A Koskela, et al.
Pageof 1